Influence of route of administration on progesterone metabolism

Maturitas

Volumn 21, Issue 3, 1995, Pages 251-257

  de Lignieres, Bruno ^a   Dennerstein, Lorraine ^b   Backstrom, Torbjorn ^c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

5 pregnanolone; 5 pregnanolone; Oral administration; Progestones; Vaginal administration

Indexed keywords

3BETA HYDROXY 5BETA PREGNAN 20 ONE; ELTANOLONE; PROGESTERONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVAGINAL DRUG ADMINISTRATION; MENOPAUSE; ORAL DRUG ADMINISTRATION; PROGESTERONE BLOOD LEVEL; PROGESTERONE METABOLISM;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; COMPARATIVE STUDY; CROSS-OVER STUDIES; DESOXYCORTICOSTERONE; DIHYDROPROGESTERONE; FEMALE; HUMAN; PREGNANOLONE; PROGESTERONE; SUPPORT, NON-U.S. GOV'T;

EID: 0028900416     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(94)00882-8     Document Type: Article

References (28)

1. International consensus conference on postmenopausal hormone therapy and the cardiovascular system
2. Antihormone activity of progesterone and progestins
3. Effect of progesterone and progestins on water and salt metabolism
4. The historic review of the clinical use of progesterone and progestin
5. A prospective randomized comparison of intramuscular or intravaginal natural progesterone as luteal phase and early pregnancy supplement
6. Prevention of endometrial hyperplasia by progesterone during longterm estradiol replacement: influence of bleeding pattern and secretory changes
7. Steroid hormone metabolites are barbituratelike modulators of the GABA receptor
8. Gammaaminobutyric acid A receptors mediate 3-alpha-hydroxy-5-alpha-pregnan-20-one-induced gonadotropin secretion
9. Inhibitory effect of 5-beta-pregnan-3-alpha-ol-20-one on gonadotropin-releasing hormone gene expression in the male rat
10. Progestogen addition during oestrogen replacement therapy: effects on vasomotor symptoms and mood
11. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome
12. Progesterone and the premenstrual syndrome: a double blind cross-over trial
13. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites
14. Differential effects of exogenous oestradiol and progesterone on mood in postmenopausal women: individual dose/effect relationship
15. Comparative bioavailability of orally and vaginally administered progesterone
16. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone
17. Physiological aspects of steroids with anaesthetic properties
18. Physiological role of 5-alpha- and 5-beta- progesterone metabolites on the CNS
19. The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex
20. Pregnanolone: a highly potent, naturally occuring hypnotic-anesthetic agent
21. The anaesthetic potency of 3-alpha-hydroxy-5-alpha-pregnan-20-one and 3-alpha-hydroxy-5-beta-pregnan-20-one, determined with an intravenous EEG-threshold method in male rats
22. Pregnanolone emulsion
23. Biliary excretion and intestinal metabolism of progesterone and estrogens in man
24. Absorption of oral progesterone is influenced by vehicle and particle size
25. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone
26. Plasma levels of psychotropic metabolites after oral and vaginal administration in women
27. Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea
28. Natural progesterone and anti-hypertensive action